-
公开(公告)号:US20110034504A1
公开(公告)日:2011-02-10
申请号:US12935472
申请日:2009-03-31
IPC分类号: A61K31/4365 , C07D471/04 , A61P9/00
CPC分类号: A61K31/496 , A61K31/4196 , A61K45/06 , A61K2300/00
摘要: [Object] To provide an excellent pharmaceutical composition for preventing and/or treating vascular diseases.[Means for Solution] Useful to provide a pharmaceutical composition for preventing and/or treating vascular diseases, which comprises 1) a COX-1 selective inhibitor and 2) clopidogrel or a pharmaceutically acceptable salt thereof. The present invention is useful as an excellent pharmaceutical composition for preventing and/or treating vascular diseases is provided and is particularly useful as a pharmaceutical composition for preventing and/or treating arterial thrombosis, ischemic heart disease, ischemic brain disease, pulmonary embolism, peripheral circulation disorder, restenosis and reocclusion, essential thrombocytosis and so on is provided.
摘要翻译: 提供用于预防和/或治疗血管疾病的优异药物组合物。 [用于溶液的方法]可用于提供用于预防和/或治疗血管疾病的药物组合物,其包括1)COX-1选择性抑制剂和2)氯吡格雷或其药学上可接受的盐。 本发明可用作预防和/或治疗血管疾病的优异药物组合物,并且特别可用作预防和/或治疗动脉血栓形成,缺血性心脏病,缺血性脑病,肺栓塞,周围循环的药物组合物 障碍,再狭窄和再闭塞,原发性血小板增多症等。
-
2.
公开(公告)号:US20080010691A1
公开(公告)日:2008-01-10
申请号:US11794946
申请日:2006-01-26
申请人: Toshiyuki Funatsu , Takuya Hirata , Yoshihiro Keto
发明人: Toshiyuki Funatsu , Takuya Hirata , Yoshihiro Keto
IPC分类号: G01N33/15
CPC分类号: G01N33/5088 , G01N2800/065
摘要: A method of screening a therapeutic agent for irritable bowel syndrome, characterized in that a test substance is administered to a conditioned fear stressed animal model and the condition of defecation and/or bowel movement thereof is measured.
摘要翻译: 筛选肠易激综合征治疗剂的方法,其特征在于,将测试物质施用于经过调理的恐惧压力的动物模型,并测量其排便和/或排便的状况。
-
公开(公告)号:US20110158930A1
公开(公告)日:2011-06-30
申请号:US13061384
申请日:2009-08-27
IPC分类号: A61K31/78 , C07D403/06 , A61P1/00 , A61P1/12
CPC分类号: A61K31/4184 , A61K31/78
摘要: A method for treatment of a patient suffering from irritable bowel syndrome with diarrhea or mixed irritable bowel syndrome, which comprises administering to the patient a therapeutically effective amount of ramosetron or a pharmaceutically acceptable salt thereof in combination with a therapeutically effective amount of polycarbophil or a pharmaceutically acceptable salt thereof.
摘要翻译: 一种用于治疗患有腹泻或混合性肠易激综合征的肠易激综合征的患者的方法,其包括向患者施用治疗有效量的雷莫司琼或其药学上可接受的盐与治疗有效量的聚卡波非或药学上 其可接受的盐。
-
-